You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TFR

Showing 1 - 25 of 94
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Treatment-free Remission
  • TFR(Treatment-Free Remission)
  • (no location specified)
Jun 27, 2022

Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
  • (no location specified)
Jun 7, 2022

Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

Not yet recruiting
  • Tyrosine Kinase Inhibitors
  • Chronic Myeloid Leukemia
  • treatment of TKI in CML
  • Poitiers, France
    Chu Poitiers
Feb 21, 2023

Chronic Myeloid Leukemia Trial in Worldwide

Recruiting
  • Chronic Myeloid Leukemia
    • Montréal, Quebec, Canada
    • +25 more
    Jul 25, 2022

    Orthodontic Retention Trial in Kuala Lumpur (Thermoformed retainers, 3D-printed retainers)

    Recruiting
    • Orthodontic Retention
    • Thermoformed retainers
    • 3D-printed retainers
    • Kuala Lumpur, Wilayah Persekutuan, Malaysia
      Orthodontic Postgraduate Clinic, Faculty of Dentistry, Universit
    Jul 26, 2023

    Neuromuscular Blockade Trial in Yvoir (Isometric Thumb Force (isometric mechanomyography) compared to TOF-Watch SX

    Not yet recruiting
    • Neuromuscular Blockade
    • Isometric Thumb Force (isometric mechanomyography) compared to TOF-Watch SX (acceleromyography)
    • Yvoir, Belgium
      CHU Dinant-Godinne
    Jul 24, 2022

    Chronic Myeloid Leukemia, Chronic Phase Trial in Spain (Ponatinib 15 MG, Acetylsalicylic acid 100 MG)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Ponatinib 15 MG
    • Acetylsalicylic acid 100 MG
    • L'Hospitalet De Llobregat, Barcelona, Spain
    • +12 more
    Feb 8, 2022

    Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Trial in Worldwide (Nilotinib)

    Completed
    Has Results
    • Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
    • Linz, Oberoesterreich, Austria
    • +207 more
    Jun 23, 2021

    Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive
      • Taipei, Taiwan
        National Taiwan University Hospital
      Jul 24, 2022

      Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Withdrawal;Drug
      • Imatinib withdrawal
      • +2 more
      • Brno, Czechia
      • +7 more
      Aug 24, 2022

      Outcomes of Tyrosine Kinase Inhibitor(TKI)Stopping in Chronic

      Recruiting
      • Folate
      • +2 more
        • Nantong, China
          Affliated Hospital of Nantong University
        Dec 13, 2021

        Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia
        • Detroit, Michigan
        • +1 more
        May 3, 2022

        Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)

        Active, not recruiting
        Has Results
        • Chronic Myelogenous Leukemia
        • Nilotinib followed by treatment-free
        • Fort Myers, Florida
        • +113 more
        Apr 25, 2022

        Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

        Active, not recruiting
        Has Results
        • Chronic Myeloid Leukemia
        • Los Angeles, California
        • +61 more
        Mar 17, 2022

        TKI Discontinuation in CML Patients of China

        Recruiting
        • Leukemia
        • +4 more
          • Shenzhen, Guangdong, China
            Shenzhen Second People's Hospital
          Mar 15, 2022

          Lenalidomide With Tumor Flare Reaction and High Tumor Burden in

          Recruiting
          • Lymphoma, Mantle-Cell
          • Graz, Austria
          • +86 more
          Oct 19, 2022

          Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)

          Recruiting
          • Philadelphia Chromosome Positive CML
          • BCR-ABL Positive Chronic Myelogenous Leukemia
          • Amiens, France
          • +27 more
          Dec 9, 2021

          Treatment Free Remission, Chronic Myeloid Leukemia Trial in Turin

          Recruiting
          • Treatment Free Remission
          • Chronic Myeloid Leukemia
            • Turin, Italy
              Division of Hematology-AO Mauriziano Hospital, University of Tur
            Nov 17, 2021

            The Significance of Release of T-follicular Helper and

            Not yet recruiting
            • Autoimmune Hemolytic Anemia
            • flowcytometry
            • (no location specified)
            Oct 22, 2021

            Key Diagnosis and Treatment Technology of Genetic and Metabolic

            Not yet recruiting
            • Diagnosis ， Treatment， Genetic and Metabolic Liver Disease
            • There is no intervention
            • (no location specified)
            Oct 27, 2022

            Glomerulonephritis, IGA Trial in Besançon (Blood collection, Urine sample)

            Not yet recruiting
            • Glomerulonephritis, IGA
            • Blood collection
            • Urine sample
            • Besançon, France
              Centre Hospitalier Universitaire de Besançon
            Mar 17, 2023

            Pancreatoduodenectomy, Clinically Relevant Postoperative Pancreatic Fistula, Internal Biodegradable Pancreatic Stent Trial in

            Recruiting
            • Pancreatoduodenectomy
            • +2 more
            • Biodegradable Stent
            • Milan, Italy
              IRCCS Ospedale San Raffaele
            Jan 26, 2023

            Chronic Myeloid Leukemia (CML) Trial in France

            Recruiting
            • Chronic Myeloid Leukemia (CML)
              • Annecy, France
              • +11 more
              Jul 18, 2023

              Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

              Recruiting
              • Chronic Myeloid Leukemia
              • +2 more
              • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
              • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
              • Houston, Texas
              • +3 more
              Jan 25, 2022

              Withdrawal of Second-generation Tyrosine Kinase Inhibitors After

              Recruiting
              • MMR on 12 Month
              • Guangzhou, Guangdong, China
              • +1 more
              Apr 21, 2022